Dosage frequency for suppression of platelet function by low dose aspirin therapy
Related Experiment Videos
Abstract:
A study of platelet aggregation and MDA production after an oral dose of 300 mg aspirin indicated that partial recovery of platelet function occurred when approximately one third of the circulating platelets had been replaced by new (uninhibited) platelets. In vitro studies on mixtures of normal and aspirin inhibited platelets indicated partial restoration of platelet aggregation and thromboxane B2 production with as little as 10% of normal platelets in some subjects. Restoration of full function required a higher proportion of normal platelets. There was considerable variation between subjects. These data suggest that complete suppression of platelet functions in all normal subjects requires daily administration of the drug.
Insights
Daily aspirin doses are needed to fully inhibit platelet function. Partial recovery of platelet aggregation and thromboxane B2 production occurs as new platelets replace inhibited ones, with significant individual variability.
Area of Science:
- Pharmacology
- Hematology
- Biochemistry
Background:
- Aspirin irreversibly inhibits cyclooxygenase-1 in platelets, impairing platelet aggregation and thromboxane production.
- Platelet function recovery depends on the generation of new, uninhibited platelets.
Purpose of the Study:
- To determine the proportion of new platelets required for the recovery of platelet function after aspirin administration.
- To investigate the in vitro restoration of platelet aggregation and thromboxane B2 production with varying ratios of normal to aspirin-inhibited platelets.
Main Methods:
- Oral administration of 300 mg aspirin to subjects.
- In vitro studies mixing normal and aspirin-inhibited platelets.
- Measurement of platelet aggregation and thromboxane B2 production.
Main Results:
- Partial recovery of platelet function was observed when approximately one-third of circulating platelets were replaced by new ones.
- In vitro, as little as 10% normal platelets restored some platelet aggregation and thromboxane B2 production in certain subjects.
- Full functional recovery required a higher proportion of normal platelets, with significant inter-individual variation.
Conclusions:
- Complete suppression of platelet function by aspirin necessitates daily administration due to the continuous replacement of inhibited platelets.
- Individual responses to aspirin vary, influencing the rate of platelet function recovery.